BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16423988)

  • 1. HIV-1 Vpr induces DNA double-strand breaks.
    Tachiwana H; Shimura M; Nakai-Murakami C; Tokunaga K; Takizawa Y; Sata T; Kurumizaka H; Ishizaka Y
    Cancer Res; 2006 Jan; 66(2):627-31. PubMed ID: 16423988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Vpr induces ATM-dependent cellular signal with enhanced homologous recombination.
    Nakai-Murakami C; Shimura M; Kinomoto M; Takizawa Y; Tokunaga K; Taguchi T; Hoshino S; Miyagawa K; Sata T; Kurumizaka H; Yuo A; Ishizaka Y
    Oncogene; 2007 Jan; 26(4):477-86. PubMed ID: 16983346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathway.
    Yoshizuka N; Yoshizuka-Chadani Y; Krishnan V; Zeichner SL
    J Virol; 2005 Sep; 79(17):11366-81. PubMed ID: 16103188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gelsolin segment 5 inhibits HIV-induced T-cell apoptosis via Vpr-binding to VDAC.
    Qiao H; McMillan JR
    FEBS Lett; 2007 Feb; 581(3):535-40. PubMed ID: 17254575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the C-terminal region of the HIV-1 accessory gene vpr do not confer clinical advantage to subjects receiving nucleoside antiretroviral therapy.
    Cavert W; Webb CH; Balfour HH
    J Infect Dis; 2004 Jun; 189(12):2181-4. PubMed ID: 15181564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Vpr-induced cell cycle abnormality by quercetin: a novel strategy for searching compounds targeting Vpr.
    Shimura M; Zhou Y; Asada Y; Yoshikawa T; Hatake K; Takaku F; Ishizaka Y
    Biochem Biophys Res Commun; 1999 Aug; 261(2):308-16. PubMed ID: 10425183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of protein phosphatase-2A1 by HIV-1 Vpr cell death causing peptide in intact CD(4+) T cells and in vitro.
    Janoo A; Morrow PW; Tung HY
    J Cell Biochem; 2005 Mar; 94(4):816-25. PubMed ID: 15578586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive effect of elongation factor 2 on apoptosis induced by HIV-1 viral protein R.
    Zelivianski S; Liang D; Chen M; Mirkin BL; Zhao RY
    Apoptosis; 2006 Mar; 11(3):377-88. PubMed ID: 16520893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV Vpr Modulates the Host DNA Damage Response at Two Independent Steps to Damage DNA and Repress Double-Strand DNA Break Repair.
    Li D; Lopez A; Sandoval C; Nichols Doyle R; Fregoso OI
    mBio; 2020 Aug; 11(4):. PubMed ID: 32753492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel nuclear import of Vpr promoted by importin alpha is crucial for human immunodeficiency virus type 1 replication in macrophages.
    Nitahara-Kasahara Y; Kamata M; Yamamoto T; Zhang X; Miyamoto Y; Muneta K; Iijima S; Yoneda Y; Tsunetsugu-Yokota Y; Aida Y
    J Virol; 2007 May; 81(10):5284-93. PubMed ID: 17344301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type 1 (HIV-1) Vpr-regulated cell death: insights into mechanism.
    Muthumani K; Choo AY; Premkumar A; Hwang DS; Thieu KP; Desai BM; Weiner DB
    Cell Death Differ; 2005 Aug; 12 Suppl 1():962-70. PubMed ID: 15832179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mitochondriotoxic domain of Vpr determines HIV-1 virulence.
    Brenner C; Kroemer G
    J Clin Invest; 2003 May; 111(10):1455-7. PubMed ID: 12750393
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of different mutated sites in vpr gene of HIV on apoptosis of host cells: experiment with HeLa cells].
    Zheng YH; Zhang CY; He Y; Gong GZ; Li H; Chen Z; Liu M; Zhou HY; Li Y; Liu C; Li J; Zhou GQ; Yin W; Yuan HL
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):614-9. PubMed ID: 19595162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vpr-induced DNA double-strand breaks: molecular mechanism and biological relevance.
    Nakai-Murakami C; Minemoto Y; Ishizaka Y
    Curr HIV Res; 2009 Mar; 7(2):109-13. PubMed ID: 19275579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Functional roles of HIV-1 accessory genes for its pathogenicity].
    Adachi A; Kamada K; Hatcho K; Yamashita T; Uchiyama T; Nomaguchi M
    Tanpakushitsu Kakusan Koso; 2007 Aug; 52(10 Suppl):1261-7. PubMed ID: 17824250
    [No Abstract]   [Full Text] [Related]  

  • 16. Human immunodeficiency virus type 1 Vpr interacts with antiapoptotic mitochondrial protein HAX-1.
    Yedavalli VS; Shih HM; Chiang YP; Lu CY; Chang LY; Chen MY; Chuang CY; Dayton AI; Jeang KT; Huang LM
    J Virol; 2005 Nov; 79(21):13735-46. PubMed ID: 16227293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fumagillin suppresses HIV-1 infection of macrophages through the inhibition of Vpr activity.
    Watanabe N; Nishihara Y; Yamaguchi T; Koito A; Miyoshi H; Kakeya H; Osada H
    FEBS Lett; 2006 May; 580(11):2598-602. PubMed ID: 16631749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural alteration of DNA induced by viral protein R of HIV-1 triggers the DNA damage response.
    Iijima K; Kobayashi J; Ishizaka Y
    Retrovirology; 2018 Jan; 15(1):8. PubMed ID: 29338752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on HIV/AIDS using the fission yeast Schizosaccharomyces pombe].
    Masuda M
    Rinsho Byori; 2005 Oct; 53(10):950-6. PubMed ID: 16296344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human immunodeficiency virus type 1 (HIV-1) nuclear import via Vpr-Importin alpha interactions as a novel HIV-1 therapy.
    Suzuki T; Yamamoto N; Nonaka M; Hashimoto Y; Matsuda G; Takeshima SN; Matsuyama M; Igarashi T; Miura T; Tanaka R; Kato S; Aida Y
    Biochem Biophys Res Commun; 2009 Mar; 380(4):838-43. PubMed ID: 19338763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.